PMID:4392059707 investigated sex differences in Alzheimer's disease. The noradrenergic system shows marked sex differences in AD risk and progression. How gonadal hormones interact with adrenergic signaling to modulate microglial surveillance, neuroinflammation, and synaptic resilience in AD is poorly understood. This gap spans basic mechanism to therapeutic targeting.
0
investigations
0
debates
paper_derived
source
Scores
Composite
0.660
Importance
0.680
Tractability
0.600
Novelty
0.700
Priority
0.630
Market Price
0.500